Kadsura heteroclita

Ethnobotanical Studies

Studies

Exploring the multifaceted therapeutic mechanism of Schisanlactone E (XTS) in APP/PS1 mouse model of Alzheimer's disease through multi-omics analysis.

Summary

Schisanlactone E (XTS) from Tujia medicine shows promise in treating Alzheimer's with anti-inflammatory and antioxidant properties. Study aims to understand XTS's therapeutic effects.

Song Z et al (2024).
Front Microbiol.
PubMed:
39044957

Xuetongsu attenuates bone destruction in collagen-induced arthritis mice by inhibiting osteoclast differentiation and promoting osteoclast apoptosis.

Zheng H et al (2024).
Int J Biochem Cell Biol.
PubMed:
38340949

Simultaneously qualitative and quantitative analysis of the representative components in Kadsura heteroclita stem by UHPLC-Q-Orbitrap HRMS.

Liu QQ et al (2021).
J Food Drug Anal.
PubMed:
35696210

Kadsura heteroclita stem ethanol extract protects against carbon tetrachloride-induced liver injury in mice via suppression of oxidative stress, inflammation, and apoptosis.

Yu HH et al (2021).
J Ethnopharmacol.
PubMed:
33091494

Phenolic Profiles, Antioxidant, and Inhibitory Activities of Kadsura heteroclita (Roxb.) Craib and Kadsura coccinea (Lem.) A.C. Sm.

Sritalahareuthai V et al (2020).
Foods.
PubMed:
32887386

Xuetonglactones A-F: Highly Oxidized Lanostane and Cycloartane Triterpenoids From Kadsura heteroclita Roxb. Craib.

Shehla N et al (2020).
Front Chem.
PubMed:
32039154

Pharmacokinetics, bioavailability, excretion, and metabolic analysis of Schisanlactone E, a bioactive ingredient from Kadsura heteroclita (Roxb) Craib, in rats by UHPLC-MS/MS and UHPLC-Q-Orbitrap HRMS.

Liu R et al (2020).
J Pharm Biomed Anal.
PubMed:
31546138